pantoprazole has been researched along with Pancreatitis in 10 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Pancreatitis: INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to investigate effects of somatostatin combined with pantoprazole on serum C-reactive protein (CRP) and intercellular adhesion molecule-1 (ICAM-1) in severe acute pancreatitis (SAP) patients." | 9.30 | Effects of Somatostatin Combined with Pantoprazole on Serum C-Reactive Protein and Intercellular Adhesion Molecule-1 in Severe Acute Pancreatitis. ( Huang, L; Liu, J; Liu, Y; Wang, G; Wang, J; Xu, X, 2019) |
| " Her postoperative course was complicated by a mucormycosis infection, gastrointestinal bleed, and necrotizing pancreatitis requiring treatment with liposomal amphotericin B and pantoprazole 80 mg twice daily." | 8.12 | Hepatitis C viral clearance with coadministration of crushed sofosbuvir/velpatasvir and high-dose pantoprazole after liver transplantation. ( Bova, SE; Freedman, SR; Pluckrose, DM; Szczepanik, A, 2022) |
| "This case report highlights a very rare adverse drug reaction caused by oral pantoprazole resulting in acute pancreatitis." | 7.78 | Oral pantoprazole-induced acute pancreatitis in an 11-year-old child. ( Das, S; Dey, JK; Ganguly, A; Ghosh, A; Mondal, S; Saha, I, 2012) |
| "Childhood-onset type 1 diabetes mellitus (DM) is a common chronic metabolic disease associated with life-threatening complications." | 5.91 | Pantoprazole Induced Acute Interstitial Nephritis in a Patient with Diabetic Ketoacidosis. ( Goncu, S; Kiremitci, S; Mengen, E; Tas, N; Tasar, S; Ucakturk, A, 2023) |
| "The objective of this study was to investigate effects of somatostatin combined with pantoprazole on serum C-reactive protein (CRP) and intercellular adhesion molecule-1 (ICAM-1) in severe acute pancreatitis (SAP) patients." | 5.30 | Effects of Somatostatin Combined with Pantoprazole on Serum C-Reactive Protein and Intercellular Adhesion Molecule-1 in Severe Acute Pancreatitis. ( Huang, L; Liu, J; Liu, Y; Wang, G; Wang, J; Xu, X, 2019) |
| "Treatment with pantoprazole did not have influence on the clinical course of acute pancreatitis." | 5.16 | [Effect of proton pump inhibitor in patients with acute pancreatitis - pilot study]. ( Hong, SP; Kim, WH; Ko, KH; Kwon, CI; Park, PW; Yoo, JH; Yoo, KH; Yoon, H, 2012) |
| " Her postoperative course was complicated by a mucormycosis infection, gastrointestinal bleed, and necrotizing pancreatitis requiring treatment with liposomal amphotericin B and pantoprazole 80 mg twice daily." | 4.12 | Hepatitis C viral clearance with coadministration of crushed sofosbuvir/velpatasvir and high-dose pantoprazole after liver transplantation. ( Bova, SE; Freedman, SR; Pluckrose, DM; Szczepanik, A, 2022) |
| "gov and Cochrane Library from inception to June 30,2021 to retrieve relevant studies using the search strategy: ("Proton pump inhibitors" OR "PPI" OR "PPIs" OR "Omeprazole" OR "Tenatoprazole" OR "Pantoprazole" OR "acid suppression therapy" OR "acid suppression drugs") AND ("pancreatitis" OR "pancreatitides")." | 4.02 | Effectiveness and safety of proton pump inhibitors for treating acute pancreatitis: A protocol for systematic review and meta analysis. ( Cheng, T; Gu, ZH; Han, TY; Liu, BF; Pan, P; Yu, H, 2021) |
| "This case report highlights a very rare adverse drug reaction caused by oral pantoprazole resulting in acute pancreatitis." | 3.78 | Oral pantoprazole-induced acute pancreatitis in an 11-year-old child. ( Das, S; Dey, JK; Ganguly, A; Ghosh, A; Mondal, S; Saha, I, 2012) |
| "Childhood-onset type 1 diabetes mellitus (DM) is a common chronic metabolic disease associated with life-threatening complications." | 1.91 | Pantoprazole Induced Acute Interstitial Nephritis in a Patient with Diabetic Ketoacidosis. ( Goncu, S; Kiremitci, S; Mengen, E; Tas, N; Tasar, S; Ucakturk, A, 2023) |
| "Acute pancreatitis is one such rare gastrointestinal manifestation of acute pancreatitis." | 1.35 | Acute abdomen due to acute pancreatitis--a rare presentation of leptospirosis. ( Antony, T; Baburaj, P; Harikrishnan, BL; Louis, F, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pluckrose, DM | 1 |
| Szczepanik, A | 1 |
| Bova, SE | 1 |
| Freedman, SR | 1 |
| Tas, N | 1 |
| Mengen, E | 1 |
| Goncu, S | 1 |
| Tasar, S | 1 |
| Kiremitci, S | 1 |
| Ucakturk, A | 1 |
| Murthy, RN | 1 |
| Viswanathan, S | 1 |
| Jain, D | 1 |
| Cheng, T | 1 |
| Liu, BF | 1 |
| Han, TY | 1 |
| Gu, ZH | 1 |
| Pan, P | 1 |
| Yu, H | 1 |
| Occhipinti, V | 1 |
| Segato, S | 1 |
| Carrara, A | 1 |
| Orlando, S | 1 |
| Conte, D | 1 |
| Liu, J | 1 |
| Wang, G | 1 |
| Liu, Y | 1 |
| Huang, L | 1 |
| Xu, X | 1 |
| Wang, J | 1 |
| Baburaj, P | 1 |
| Antony, T | 1 |
| Louis, F | 1 |
| Harikrishnan, BL | 1 |
| Hackert, T | 1 |
| Tudor, S | 1 |
| Felix, K | 1 |
| Dovshanskiy, D | 1 |
| Hartwig, W | 1 |
| Simon, WA | 1 |
| Werner, J | 1 |
| Das, S | 1 |
| Ganguly, A | 1 |
| Ghosh, A | 1 |
| Mondal, S | 1 |
| Dey, JK | 1 |
| Saha, I | 1 |
| Yoo, JH | 1 |
| Kwon, CI | 1 |
| Yoo, KH | 1 |
| Yoon, H | 1 |
| Kim, WH | 1 |
| Ko, KH | 1 |
| Hong, SP | 1 |
| Park, PW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| PROTon Pump Inhibitors and Stent OCclusion Rate Of Lumen Apposing Metal Stents (PROTOCOL)[NCT05817721] | 639 participants (Anticipated) | Observational | 2023-05-05 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for pantoprazole and Pancreatitis
| Article | Year |
|---|---|
Effects of Somatostatin Combined with Pantoprazole on Serum C-Reactive Protein and Intercellular Adhesion Molecule-1 in Severe Acute Pancreatitis.
Topics: Adult; C-Reactive Protein; Drug Therapy, Combination; Female; Hormones; Humans; Intercellular Adhesi | 2019 |
[Effect of proton pump inhibitor in patients with acute pancreatitis - pilot study].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; | 2012 |
8 other studies available for pantoprazole and Pancreatitis
| Article | Year |
|---|---|
Hepatitis C viral clearance with coadministration of crushed sofosbuvir/velpatasvir and high-dose pantoprazole after liver transplantation.
Topics: Adult; Antiviral Agents; Female; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Liver Trans | 2022 |
Pantoprazole Induced Acute Interstitial Nephritis in a Patient with Diabetic Ketoacidosis.
Topics: Acute Disease; Child; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Humans; Pancreatitis; Pantop | 2023 |
Multiple ecchymotic signs in acute pancreatitis.
Topics: Abdomen; Abdominal Pain; Acute Disease; Adult; Analgesics, Opioid; Drug Therapy, Combination; Ecchym | 2020 |
Effectiveness and safety of proton pump inhibitors for treating acute pancreatitis: A protocol for systematic review and meta analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Humans; Meta-Analysis as Topic; Omeprazole; Pancreatitis; P | 2021 |
ERCP or NO ERCP: the case report of a frail patient.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Aged; Angiotensin-Converting Enzyme Inhibit | 2018 |
Acute abdomen due to acute pancreatitis--a rare presentation of leptospirosis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdomen, Acute; Acute Disease; Amylases; Diagnosis, Differe | 2008 |
Effects of pantoprazole in experimental acute pancreatitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Cell Movement; Ceruletide; H(+)-K(+)-Exchanging AT | 2010 |
Oral pantoprazole-induced acute pancreatitis in an 11-year-old child.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Child; Gastroesophageal Reflux; Human | 2012 |